Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
life sciences
national blog main
alnylam pharmaceuticals
amgen
andrew berens
avapritinib
blueprint medicines
boston
boston top stories
cancer
cholesterol
deciphera pharmaceuticals
gastrointestinal stromal tumor
gist
gleevec
imatinib
inclisiran
national top stories
new york
new york blog main
new york top stories
pcsk9 inhibitors
praluent
regeneron pharmaceuticals
regorafenib
repatha
ripretinib
steve hoerter
stivarga
sunitinib
sutent
svb leerink
the medicines co.
What
drug
fda
2
×
filing
morning
2
×
announced
approval
blueprint
bringing
cancer
chasing
cholesterol
clears
closer
deadly
deciphera
forms
gi
inched
lowering
market
medco
medicine
medicines
pharamceuticals
phase
plans
positive
preps
result
seek
tests
touting
treats
tumor
twice
type
yearly
Language
unset
2
×
Current search:
morning
×
unset
×
fda
×
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
